\-\ Texto\\:\\ \ \(0\)\
\-\ cv\\:\\ rrr\\ with\\ out\\ r\\/g\\/m\ \(0\)\
\-\ pulm\\:\\ ctab\\ w\\/o\\ r\\/r\\/w\ \(0\)\
\-\ the\\ treatment\\ for\\ mac\\ is\\ currently\\ debated\\,\\ but\\ it\\ tends\\ to\\ somewhat\\ mirror\\ tb\\ treatment\\.4\\,5\\ the\\ pt\\ was\\ started\\ on\\ clarithromycin\\ 500mg\\ po\\ bid\\ with\\ ethambutol\\ 20mg\\/kg\\ qday\\,\\ rifampin\\ 600mg\\ qday\\ for\\ 12\\ months\\ until\\ culture\\ negative\\.4\\,5\\ streptomycin\\ 1g\\ 3\\-5\\ days\\ qwek\\ for\\ 6\\-12\\ weeks\\ is\\ specifically\\ for\\ treatment\\ of\\ the\\ cavitation\\.5\ \(0\)\
\-\ ct\\ \\(09\\-dec\\-2008\\)\ \(0\)\
\-\ 1\\.\\ no\\ pe\\ or\\ dvt\\.\\ \ \(0\)\
\-\ 2\\.\\ consolidation\\ of\\ the\\ apical\\ posterior\\ segment\\ of\\ the\\ right\\ upper\\ lobe\\ \\ consistent\\ with\\ pneumonia\\.\\ \ \(0\)\
\-\ 3\\.\\ diffuse\\ interstitial\\ disease\\,\\ pulmonary\\ fibrosis\\ and\\ traction\\ \\ bronchiectasis\\ consistent\\ with\\ history\\ of\\ sarcoidosis\\.\ \(0\)\
\-\ chest\\ pa\\/lat\\ \\(09\\-dec\\-2008\\)\\:\ \(0\)\
\-\ 1\\.\\ diminished\\ right\\ lower\\ lobe\\ infiltrative\\ process\\.\ \(0\)\
\-\ 2\\.\\ diffuse\\ bilateral\\ interstitial\\ lung\\ disease\\,\\ not\\ appreciably\\ changed\\.\\ \\ \\ \ \(0\)\
\-\ 3\\.\\ persistent\\ right\\ apical\\ pleural\\ thickening\\.\ \(0\)\
\-\ ct\\ \\(06\\-apr\\-2009\\)\ \(0\)\
\-\ 1\\.\\ increased\\ right\\ middle\\ lobe\\ consolidation\\ with\\ a\\ 2\\.4\\ cm\\ cavitation\\.\ \(0\)\
\-\ 2\\.\\ nearly\\ resolved\\ right\\ upper\\ lobe\\ consolidation\\.\\ \\ \\ \ \(0\)\
\-\ 3\\.\\ traction\\ bronchiectasis\\ and\\ fibrosis\\ as\\ described\\ as\\ can\\ be\\ seen\\ with\\ sarcoidosis\\.\\ \\ \\ \ \(0\)\
\-\ 4\\.\\ at\\ the\\ lung\\ bases\\,\\ there\\ are\\ fibrotic\\ and\\ emphysematous\\ like\\ changes\\.\\ \\ \\ \ \(0\)\
\-\ 5\\.\\ stable\\ mild\\ mediastinal\\ lymphadenopathy\\.\ \(0\)\
\-\ mycobacterial\\ avium\\ complex\\ pulmonary\\ infection\ \(0\)\
\-\ \\â\\€\\¢\\ sacoidosis\\ exacerbation\ \(0\)\
\-\ \\â\\€\\¢\\ tb\ \(0\)\
\-\ \\â\\€\\¢\\ ntm\ \(0\)\
\-\ \\â\\€\\¢\\ pulmonary\\ scc\ \(0\)\
\-\ \\â\\€\\¢\\ fungal\\ infection\ \(1\)\
\-\ patient\\ is\\ a\\ 49\\ y\\/o\\ ad\\ usn\\ male\\ with\\ history\\ of\\ sarcoidosis\\ presented\\ to\\ his\\ pcm\\ in\\ early\\ december\\ with\\ a\\ 4\\ day\\ history\\ of\\ dyspnea\\ and\\ myalgias\\.\\ he\\ was\\ originally\\ seen\\ by\\ a\\ civilian\\ provider\\ and\\ was\\ given\\ azitrhomycin\\ 250mg\\ which\\ had\\ no\\ effect\\ on\\ his\\ condition\\.\\ upon\\ admission\\ he\\ noted\\ fatigue\\,\\ cough\\ and\\ pleuritic\\ chest\\ pain\\.\\ his\\ pulse\\ oximetry\\ was\\ 88\\%\\ while\\ walking\\,\\ whereas\\ his\\ normal\\ baseline\\ is\\ 95\\%\\.\\ his\\ home\\ medications\\ include\\ advair\\ and\\ spiriva\\.\\ pt\\ was\\ admitted\\ to\\ hospital\\ for\\ sarcoid\\ exacerbation\\ with\\ an\\ elevated\\ wbc\\ of\\ 11\\.3\\.\\ he\\ was\\ started\\ on\\ prednisone\\ taper\\ and\\ levofloxacin\\ 750mg\\ qday\\ for\\ 21\\ days\\.\\ a\\ chest\\ posterior\\-anterior\\ and\\ lateral\\ x\\-ray\\ showed\\ rml\\ and\\ rul\\ opacity\\ consistent\\ with\\ infection\\.\\ a\\ ct\\,\\ pe\\ protocol\\ 1\\.25\\ mm\\ contiguous\\ axial\\ images\\ with\\ iv\\ contrast\\ was\\ performed\\ which\\ showed\\ consolidation\\ of\\ the\\ apical\\ posterior\\ segment\\ of\\ the\\ right\\ upper\\ lobe\\ consistent\\ with\\ pneumonia\\.\\ the\\ patient\\ was\\ discharged\\ from\\ the\\ hospital\\.\\ he\\ returned\\ to\\ his\\ pcm\\ intermittently\\ with\\ very\\ little\\ improvement\\.\\ in\\ april\\ he\\ returned\\ to\\ his\\ pcm\\ with\\ thick\\ green\\ sputum\\,\\ fevers\\ of\\ 102\\.9\\ and\\ nightsweats\\ while\\ on\\ levofloxacin\\.\\ a\\ sputum\\ sample\\ was\\ taken\\ which\\ showed\\ candida\\ albicans\\ and\\ afb\\.\\ the\\ patient\\ was\\ isolated\\ for\\ tb\\ at\\ that\\ time\\,\\ and\\ the\\ reflexive\\ pcr\\ showed\\ the\\ afb\\ to\\ be\\ mycobacterium\\ avium\\ complex\\ \\(mac\\)\\ which\\ is\\ a\\ nontuberculous\\ mycobacteria\\ \\(ntm\\)\\.\\ a\\ chest\\ ct\\ without\\ contrast\\,\\ 5\\ mm\\ thick\\ axial\\ slices\\,\\ was\\ obtained\\ which\\ showed\\ increased\\ right\\ middle\\ lobe\\ consolidation\\ with\\ a\\ 2\\.4\\ cm\\ cavitation\\ and\\ nearly\\ resolved\\ right\\ upper\\ lobe\\ consolidation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ consolidation\\:\\ 0\\.05170525872209145\ \(0\)\
\-\ qday\\:\\ 0\\.04658092234586552\ \(0\)\
\-\ pcm\\:\\ 0\\.039313480871061075\ \(0\)\
\-\ 09\\-dec\\-2008\\:\\ 0\\.035474923235277664\ \(0\)\
\-\ avium\\:\\ 0\\.035474923235277664\ \(0\)\
\-\ his\\:\\ 0\\.03468857785418214\ \(0\)\
\-\ ntm\\:\\ 0\\.032685598565016315\ \(0\)\
\-\ levofloxacin\\:\\ 0\\.032685598565016315\ \(0\)\
\-\ lobe\\:\\ 0\\.032384864055261045\ \(0\)\
\-\ mac\\:\\ 0\\.029896273894754962\ \(0\)\
\-\ apical\\:\\ 0\\.029720511826091776\ \(0\)\
\-\ showed\\:\\ 0\\.028187155612914454\ \(0\)\
\-\ cavitation\\:\\ 0\\.025153195438651757\ \(0\)\
\-\ tb\\:\\ 0\\.02483926393264033\ \(0\)\
\-\ afb\\:\\ 0\\.02407366229340154\ \(0\)\
\-\ he\\:\\ 0\\.02398578814922555\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.023297935813069843\ \(0\)\
\-\ sputum\\:\\ 0\\.021924436997907543\ \(0\)\
\-\ was\\:\\ 0\\.02187334556207355\ \(0\)\
\-\ 2\\.4\\:\\ 0\\.021404470271629852\ \(0\)\
\-\ exacerbation\\:\\ 0\\.021404470271629852\ \(0\)\
\-\ traction\\:\\ 0\\.020530971256588294\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.0200679156035308\ \(0\)\
\-\ nearly\\:\\ 0\\.01893217126677339\ \(0\)\
\-\ thick\\:\\ 0\\.018047424884024818\ \(0\)\
\-\ r\\/r\\/w\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ treatment\\.4\\,5\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 20mg\\/kg\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ negative\\.4\\,5\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ streptomycin\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ qwek\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ cavitation\\.5\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 06\\-apr\\-2009\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ sacoidosis\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ azitrhomycin\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 11\\.3\\.\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 750mg\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 102\\.9\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ reflexive\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ nontuberculous\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 3\\.\\:\\ 0\\.017649140113525516\ \(0\)\
\-\ returned\\:\\ 0\\.017597050975759285\ \(0\)\
\-\ consistent\\:\\ 0\\.016863567555985542\ \(0\)\
\-\ interstitial\\:\\ 0\\.01682410235708999\ \(0\)\
\-\ resolved\\:\\ 0\\.016670783056356508\ \(0\)\
\-\ upper\\:\\ 0\\.01659622137117681\ \(0\)\
\-\ chest\\:\\ 0\\.016456571429034356\ \(0\)\
\-\ 2\\.\\:\\ 0\\.01640308335090699\ \(0\)\
\-\ r\\/g\\/m\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ 1g\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ appreciably\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ 250mg\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ spiriva\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ 1\\.\\:\\ 0\\.016111805832782298\ \(0\)\
\-\ which\\:\\ 0\\.016047732266021617\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0157647319074033\ \(0\)\
\-\ clarithromycin\\:\\ 0\\.015526974115288509\ \(0\)\
\-\ ethambutol\\:\\ 0\\.015526974115288509\ \(0\)\
\-\ nightsweats\\:\\ 0\\.015526974115288509\ \(0\)\
\-\ pe\\:\\ 0\\.015447825680265287\ \(0\)\
\-\ started\\:\\ 0\\.015338318382378428\ \(0\)\
\-\ fibrosis\\:\\ 0\\.015311400925031157\ \(0\)\
\-\ pulmonary\\:\\ 0\\.01506972018241487\ \(0\)\
\-\ segment\\:\\ 0\\.01500169854621374\ \(0\)\
\-\ infection\\:\\ 0\\.014994063827401248\ \(0\)\
\-\ posterior\\-anterior\\:\\ 0\\.014948136947377481\ \(0\)\
\-\ right\\:\\ 0\\.014513186464553992\ \(0\)\
\-\ debated\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ 500mg\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ advair\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ 1\\.25\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ albicans\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ pneumonia\\:\\ 0\\.014214546057257586\ \(0\)\
\-\ rifampin\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ 600mg\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ myalgias\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ civilian\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ mycobacteria\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ 6\\-12\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ taper\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ slices\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ complex\\:\\ 0\\.013770184618165541\ \(0\)\
\-\ usn\\:\\ 0\\.013553474612246806\ \(0\)\
\-\ intermittently\\:\\ 0\\.013553474612246806\ \(0\)\
\-\ oximetry\\:\\ 0\\.013316486612938187\ \(0\)\
\-\ mycobacterium\\:\\ 0\\.013104493623687027\ \(0\)\
\-\ hospital\\:\\ 0\\.012946062233272127\ \(0\)\
\-\ green\\:\\ 0\\.012912722638165248\ \(0\)\
\-\ pt\\:\\ 0\\.012785367221862184\ \(0\)\
\-\ rml\\:\\ 0\\.01273764944502716\ \(0\)\
\-\ sample\\:\\ 0\\.01273764944502716\ \(0\)\
\-\ candida\\:\\ 0\\.01273764944502716\ \(0\)\
\-\ pcr\\:\\ 0\\.01273764944502716\ \(0\)\
\-\ mm\\:\\ 0\\.012644648518289761\ \(0\)\
\-\ mirror\\:\\ 0\\.012576597719325878\ \(0\)\
\-\ bid\\:\\ 0\\.012576597719325878\ \(0\)\
\-\ middle\\:\\ 0\\.012576092433168765\ \(0\)\
\-\ 3\\-5\\:\\ 0\\.012427487111370704\ \(0\)\
\-\ fibrotic\\:\\ 0\\.01228866845646738\ \(0\)\
\-\ scc\\:\\ 0\\.01228866845646738\ \(0\)\
\-\ april\\:\\ 0\\.01228866845646738\ \(0\)\
\-\ rul\\:\\ 0\\.012158812277116132\ \(0\)\
\-\ december\\:\\ 0\\.01203683114670077\ \(0\)\
\-\ pleuritic\\:\\ 0\\.01203683114670077\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.011921824277807514\ \(0\)\
\-\ ad\\:\\ 0\\.011709831288556353\ \(0\)\
\-\ pulm\\:\\ 0\\.011428620136896075\ \(0\)\
\-\ tends\\:\\ 0\\.011342987109896485\ \(0\)\
\-\ 88\\:\\ 0\\.011260850299996576\ \(0\)\
\-\ pa\\/lat\\:\\ 0\\.011032824776240029\ \(0\)\
\-\ emphysematous\\:\\ 0\\.011032824776240029\ \(0\)\
\-\ changed\\:\\ 0\\.010894006121336706\ \(0\)\
\-\ dvt\\:\\ 0\\.010828030622698898\ \(0\)\
\-\ while\\:\\ 0\\.010819514043671282\ \(0\)\
\-\ ctab\\:\\ 0\\.010642168811570095\ \(0\)\
\-\ provider\\:\\ 0\\.010583843787680252\ \(0\)\
\-\ days\\:\\ 0\\.010539534391034116\ \(0\)\
\-\ diffuse\\:\\ 0\\.010410492637325212\ \(0\)\
\-\ for\\:\\ 0\\.010269128854122749\ \(0\)\
\-\ whereas\\:\\ 0\\.010216999609020382\ \(0\)\
\-\ baseline\\:\\ 0\\.010169654543808724\ \(0\)\
\-\ prednisone\\:\\ 0\\.010169654543808724\ \(0\)\
\-\ lung\\:\\ 0\\.009960398874200187\ \(0\)\
\-\ contiguous\\:\\ 0\\.009906837275363928\ \(0\)\
\-\ infiltrative\\:\\ 0\\.0098661879648659\ \(0\)\
\-\ po\\:\\ 0\\.009826343644350448\ \(0\)\
\-\ bases\\:\\ 0\\.009826343644350448\ \(0\)\
\-\ axial\\:\\ 0\\.009814050205504514\ \(0\)\
\-\ w\\/o\\:\\ 0\\.00971133677545719\ \(0\)\
\-\ originally\\:\\ 0\\.00971133677545719\ \(0\)\
\-\ 95\\:\\ 0\\.00967441697934412\ \(0\)\
\-\ specifically\\:\\ 0\\.009638162441109354\ \(0\)\
\-\ ct\\:\\ 0\\.009620150127903767\ \(0\)\
\-\ cv\\:\\ 0\\.009533160925675611\ \(0\)\
\-\ 49\\:\\ 0\\.009533160925675611\ \(0\)\
\-\ diminished\\:\\ 0\\.009401174441800737\ \(0\)\
\-\ little\\:\\ 0\\.00933829206050475\ \(0\)\
\-\ protocol\\:\\ 0\\.00924750647643942\ \(0\)\
\-\ cm\\:\\ 0\\.009223163451979823\ \(0\)\
\-\ fatigue\\:\\ 0\\.009189181452549575\ \(0\)\
\-\ culture\\:\\ 0\\.00916064093948729\ \(0\)\
\-\ isolated\\:\\ 0\\.008945816039234361\ \(0\)\
\-\ pulse\\:\\ 0\\.00887082329316347\ \(0\)\
\-\ walking\\:\\ 0\\.008822337273889707\ \(0\)\
\-\ sarcoid\\:\\ 0\\.008822337273889707\ \(0\)\
\-\ rrr\\:\\ 0\\.00877499220867805\ \(0\)\
\-\ somewhat\\:\\ 0\\.00845150484331034\ \(0\)\
\-\ increased\\:\\ 0\\.008412413608851733\ \(0\)\
\-\ fungal\\:\\ 0\\.008335391528178254\ \(0\)\
\-\ home\\:\\ 0\\.008172893828692422\ \(0\)\
\-\ fevers\\:\\ 0\\.008172893828692422\ \(0\)\
\-\ dyspnea\\:\\ 0\\.008138498590544937\ \(0\)\
\-\ opacity\\:\\ 0\\.008038705952437549\ \(0\)\
\-\ improvement\\:\\ 0\\.008022544641175447\ \(0\)\
\-\ \\%\\:\\ 0\\.008021412609038261\ \(0\)\
\-\ a\\:\\ 0\\.00797987528810063\ \(0\)\
\-\ like\\:\\ 0\\.007959167041458402\ \(0\)\
\-\ posterior\\:\\ 0\\.007926110859969613\ \(0\)\
\-\ discharged\\:\\ 0\\.007882653167033375\ \(0\)\
\-\ 21\\:\\ 0\\.007780198256716962\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.007751858739852296\ \(0\)\
\-\ contrast\\:\\ 0\\.007697286466027789\ \(0\)\
\-\ medications\\:\\ 0\\.007669159191189214\ \(0\)\
\-\ admission\\:\\ 0\\.007576785546714209\ \(0\)\
\-\ until\\:\\ 0\\.007551153704103686\ \(0\)\
\-\ admitted\\:\\ 0\\.007427674938759033\ \(0\)\
\-\ 5\\.\\:\\ 0\\.007415733821012928\ \(0\)\
\-\ described\\:\\ 0\\.007322673423325291\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.007311337773992784\ \(0\)\
\-\ mediastinal\\:\\ 0\\.007300065630031677\ \(0\)\
\-\ \\(\\:\\ 0\\.0072672205859543315\ \(0\)\
\-\ condition\\:\\ 0\\.007190686939450415\ \(0\)\
\-\ \\)\\:\\ 0\\.007178447606773693\ \(0\)\
\-\ taken\\:\\ 0\\.0071695070340440014\ \(0\)\
\-\ history\\:\\ 0\\.007124031414730885\ \(0\)\
\-\ stable\\:\\ 0\\.0070869488918350225\ \(0\)\
\-\ 12\\:\\ 0\\.007037018974089098\ \(0\)\
\-\ upon\\:\\ 0\\.007027179969473018\ \(0\)\
\-\ treatment\\:\\ 0\\.006960229213685663\ \(0\)\
\-\ persistent\\:\\ 0\\.006857840347095331\ \(0\)\
\-\ \\:\\:\\ 0\\.006822584402358139\ \(0\)\
\-\ currently\\:\\ 0\\.006813224939662087\ \(0\)\
\-\ seen\\:\\ 0\\.006795282153189901\ \(0\)\
\-\ 4\\.\\:\\ 0\\.006769577405232994\ \(0\)\
\-\ pleural\\:\\ 0\\.006676760963125345\ \(0\)\
\-\ process\\:\\ 0\\.0066198500700899695\ \(0\)\
\-\ cough\\:\\ 0\\.006588037985529321\ \(0\)\
\-\ \\,\\:\\ 0\\.006536259127177964\ \(0\)\
\-\ early\\:\\ 0\\.006288046216584383\ \(0\)\
\-\ iv\\:\\ 0\\.006274496856058539\ \(0\)\
\-\ wbc\\:\\ 0\\.006267756238583123\ \(0\)\
\-\ very\\:\\ 0\\.006241017340960019\ \(0\)\
\-\ obtained\\:\\ 0\\.006112406641335699\ \(0\)\
\-\ effect\\:\\ 0\\.006087642360300292\ \(0\)\
\-\ given\\:\\ 0\\.005894193948725036\ \(0\)\
\-\ elevated\\:\\ 0\\.005833634529897511\ \(0\)\
\-\ thickening\\:\\ 0\\.0058282184500872275\ \(0\)\
\-\ on\\:\\ 0\\.005826084606562802\ \(0\)\
\-\ out\\:\\ 0\\.005682200959473876\ \(0\)\
\-\ is\\:\\ 0\\.005656848877109916\ \(0\)\
\-\ disease\\:\\ 0\\.005620674210123558\ \(0\)\
\-\ day\\:\\ 0\\.005458671688838893\ \(0\)\
\-\ be\\:\\ 0\\.005302843957118428\ \(0\)\
\-\ as\\:\\ 0\\.005201519138406953\ \(0\)\
\-\ patient\\:\\ 0\\.005170575035712603\ \(0\)\
\-\ to\\:\\ 0\\.005155751812188969\ \(0\)\
\-\ and\\:\\ 0\\.00507067621780897\ \(0\)\
\-\ 5\\:\\ 0\\.005030503868096909\ \(0\)\
\-\ changes\\:\\ 0\\.004927661924014207\ \(0\)\
\-\ weeks\\:\\ 0\\.004879834520927865\ \(0\)\
\-\ time\\:\\ 0\\.004856340497463406\ \(0\)\
\-\ include\\:\\ 0\\.004823246454789309\ \(0\)\
\-\ performed\\:\\ 0\\.004793920183555974\ \(0\)\
\-\ 4\\:\\ 0\\.004790687937986007\ \(0\)\
\-\ y\\/o\\:\\ 0\\.004761829033842336\ \(0\)\
\-\ months\\:\\ 0\\.004696058943038365\ \(0\)\
\-\ presented\\:\\ 0\\.004686836287771448\ \(0\)\
\-\ at\\:\\ 0\\.004659006651233936\ \(0\)\
\-\ mild\\:\\ 0\\.0045276729455354875\ \(0\)\
\-\ bilateral\\:\\ 0\\.004172671487554213\ \(0\)\
\-\ noted\\:\\ 0\\.004075294141755722\ \(0\)\
\-\ without\\:\\ 0\\.004048316230096902\ \(0\)\
\-\ can\\:\\ 0\\.0038998437675434\ \(0\)\
\-\ lower\\:\\ 0\\.0038669256928850356\ \(0\)\
\-\ it\\:\\ 0\\.0038648860855795106\ \(0\)\
\-\ lateral\\:\\ 0\\.0037156298704719326\ \(0\)\
\-\ had\\:\\ 0\\.00370995939485052\ \(0\)\
\-\ but\\:\\ 0\\.0036670086539910217\ \(0\)\
\-\ the\\:\\ 0\\.0036161784731330695\ \(0\)\
\-\ with\\:\\ 0\\.003531313161666692\ \(0\)\
\-\ no\\:\\ 0\\.003462551914301014\ \(0\)\
\-\ images\\:\\ 0\\.003298317690038942\ \(0\)\
\-\ male\\:\\ 0\\.0031090654685864655\ \(0\)\
\-\ that\\:\\ 0\\.002969780137945319\ \(0\)\
\-\ by\\:\\ 0\\.0028629193224242954\ \(0\)\
\-\ normal\\:\\ 0\\.002695397292955938\ \(0\)\
\-\ there\\:\\ 0\\.002558783815824927\ \(0\)\
\-\ from\\:\\ 0\\.0025481603886402665\ \(0\)\
\-\ not\\:\\ 0\\.002484544611150776\ \(0\)\
\-\ an\\:\\ 0\\.00237759530037169\ \(0\)\
\-\ of\\:\\ 0\\.002344140861126528\ \(0\)\
\-\ are\\:\\ 0\\.0023438106087114723\ \(0\)\
\-\ pain\\:\\ 0\\.0020998152264199896\ \(0\)\
\-\ or\\:\\ 0\\.0020151363158223494\ \(0\)\
\-\ \\.\\:\\ 0\\.0017856909505707384\ \(0\)\
\-\ in\\:\\ 0\\.0016957635015704426\ \(0\)\
